Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically-designed, randomized, placebo-controlled studies

被引：0
|
作者：
Bingham, C. O.
Sebba, A. I.
Rubin, B. R.
Ruoff, G. E.
Kremer, J.
Bird, S.
Smugar, S. S.
Fitzgerald, B. J.
O'Brien, K.
Tershakovec, A. M.
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Univ N Texas, Ft Worth, TX USA
[3] Westside Family Med Ctr, Kalamazoo, MI USA
[4] Ctr Rheumatol, Albany, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies
    Bingham, C. O., III
    Sebba, A. I.
    Rubin, B. R.
    Ruoff, G. E.
    Kremer, J.
    Bird, S.
    Smugar, S. S.
    Fitzgerald, B. J.
    O'Brien, K.
    Tershakovec, A. M.
    [J]. RHEUMATOLOGY, 2007, 46 (03) : 496 - 507
  • [2] A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis
    Puopolo, A.
    Boice, J. A.
    Fidelholtz, J. L.
    Littlejohn, T. W.
    Miranda, P.
    Berrocal, A.
    Ko, A.
    Cichanowitz, N.
    Reicin, A. S.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2007, 15 (12) : 1348 - 1356
  • [3] Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies
    Birbara, C
    Ruoff, G
    Sheldon, E
    Valenzuela, C
    Rodgers, A
    Petruschke, RA
    Chang, DJ
    Tershakovec, AM
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (01) : 199 - 210
  • [4] Treatment of osteoarthritis patients with rofecoxib 12.5 mg and celecoxib 200 mg: A randomized, placebo-controlled trial
    Ruoff, G
    Gilderman, L
    Cohen, S
    Valenzuela, C
    Rodgers, A
    Petruschke, R
    Terschakovec, A
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2004, 12 : S87 - S88
  • [5] Comparable efficacy of rofecoxib 12.5 mg and celecoxib 200 mg in the treatment of patients with osteoarthritis: A randomized, controlled trial
    Birbara, C
    Sheldon, E
    Farrell, J
    Rodgers, A
    Petruschke, R
    Robertson, D
    Chang, DJ
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 373 - 374
  • [6] Rofecoxib 12.5 mg, rofecoxib 25mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies
    Smugar, Steven S.
    Schnitzer, Thomas J.
    Weaver, Arthur L.
    Rubin, Bernard R.
    Polis, Adam B.
    Tershakovec, Andrew M.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (07) : 1353 - 1367
  • [7] Efficacy and Safety of Duloxetine 30 mg/d in Patients With Fibromyalgia A Randomized, Double-blind, Placebo-controlled Study
    Arnold, Lesley M.
    Zhang, Shuyu
    Pangallo, Beth A.
    [J]. CLINICAL JOURNAL OF PAIN, 2012, 28 (09): : 775 - 781
  • [8] Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial
    Wiesenhutter, CW
    Boice, JA
    Ko, A
    Sheldon, EA
    Murphy, FT
    Wittmer, BA
    Aversano, ML
    Reicin, AS
    [J]. MAYO CLINIC PROCEEDINGS, 2005, 80 (04) : 470 - 479
  • [9] Efficacy and Safety of Desvenlafaxine 25 and 50 Mg/Day in a Randomized, Placebo-Controlled Study of Depressed Outpatients
    Iwata, Nakao
    Tourian, Karen A.
    Hwang, Eunhee
    Mele, Linda
    Vialet, Cecile
    [J]. JOURNAL OF PSYCHIATRIC PRACTICE, 2013, 19 (01) : 5 - 14
  • [10] Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy of Lanreotide 30 mg PR in the Treatment of Pancreatic and Enterocutaneous Fistulae
    Gayral, Francois
    Campion, Jean-Pierre
    Regimbeau, Jean-Marc
    Blumberg, Joelle
    Maisonobe, Pascal
    Topart, Philippe
    Wind, Philippe
    [J]. ANNALS OF SURGERY, 2009, 250 (06) : 872 - 877
12345